Akebia Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Akebia Therapeutics Inc
CIK #0001517022
EDGAR Form CIK 2011 - 2026
10-K [0001517022]
10-Q [0001517022]
3 [0001517022]
4 [0001517022]
5 [0001517022]
8-K [0001517022]
SC 13D [0001517022]
SC 13G [0001517022]
Form 13D/13G Filer Form 13D/13G Subject Filed
State Street Corp Akebia Therapeutics Inc [2026-05-12]
State Street Corp Akebia Therapeutics Inc [2026-02-09]
Vanguard Group Inc Akebia Therapeutics Inc [2025-04-30]
BlackRock Inc Akebia Therapeutics Inc [2024-11-08]
BlackRock Inc Akebia Therapeutics Inc [2024-10-22]
Satter Muneer A Akebia Therapeutics Inc [2022-12-19]
BlackRock Inc Akebia Therapeutics Inc [2022-07-08]
State Street Corp Akebia Therapeutics Inc [2021-02-11]
Vanguard Group Inc Akebia Therapeutics Inc [2021-02-10]
Wellington Management Group LLP Akebia Therapeutics Inc [2020-11-10]
View All
Form 3/4/5 Subject 2011 - 2026
Ostrowski Erik
Akebia Therapeutics Inc
Adams Adrian
Smith Cynthia
Rogers Michael W
Zumwalt Leanne M
Frieson Ron
Wolf Myles
Vickers Philip J
Butler John P
Malabre Richard C
Rucci Carolyn M
Grund Nicholas
Burke Steven Keith
Gilman Steven C
Dahan Michel
Hadas Nicole R
Snow Ellen
Spellman David A
Cotreau Violetta
Faulkingham Dell
Heffernan Michael Thomas
Gowen Maxine
Enyedy Mark J
Amello Jason
Tubridy Karen L
Canute Scott A
Morrison Jodie Pope
Jain Rita
Satter Muneer A
Wyzga Michael S
Nash Duane
Clayman Michael D
Renaud Ronald C JR
Maroni Bradley
Dalal Anupam
Shalwitz Robert
Novartis BioVentures Ltd
Novo Holdings A/S
Dueholm Kim
Nielsen Jack
Venture Investors Early Stage Fund IV LP
Ganser Roger H
Adox James R
Arida George
Weiss Paul M
Button Scott
Venture Investors LLC
NEIS John
Viesf IV GP LLC
Peterson Loren G
Venture Investors Southeast LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Akebia Therapeutics Inc AKBA
Common Stock
2026-03-04 Buy 69,270 $1.25 86,588
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 36,142 $1.39 50,237
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 20,701 $1.39 28,774
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 53,585 $1.39 74,483
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 27,544 $1.39 38,286
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 83,689 $1.39 116,328
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 21,582 $1.39 29,999
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 114,891 $1.39 159,698
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 31,244 $1.39 43,429
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 34,951 $1.39 48,582
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 96,065 $1.39 133,530
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 25,382 $1.39 35,281
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Grant 175,250 $1.41 247,102
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 13,382 $1.39 18,601
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 25,375 $1.39 35,271
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 16,846 $1.39 23,416
Akebia Therapeutics Inc AKBA
Common Stock
2026-02-02 Sell 46,660 $1.39 64,857
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
2026-01-30 Grant 320,000 $0.00
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
2026-01-30 Grant 320,000 $0.00
Akebia Therapeutics Inc AKBA
Common Stock
2026-01-30 Grant 204,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com